Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3231 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y114-18001 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-72 |
filingDate |
2006-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2009-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2009506763-A |
titleOfInvention |
Novel tyrosinase-specific antigene oligonucleotides as depigmenting agents |
abstract |
The present invention relates to an antigene oligonucleotide that specifically hybridizes with a gene encoding human tyrosinase by Hoogsteen-type pairing between complementary bases, and the oligonucleotide forms a triple helical structure with the human tyrosinase gene. To do. The invention also relates to the use of said oligonucleotides as skin depigmenting or skin bleaching agents in cosmetic or dermatological compositions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9249413-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007291062-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013527134-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9404110-B2 |
priorityDate |
2005-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |